Discrimination has no place in American prescription drug coverage


If someone is older, sicker or more disabled, should less value be placed on treating them? Most Americans would be repulsed by the very question. However, one organization is using questionable methodology to determine whether medical treatments are worth it or not for the people most desperately in need.

The Institute for Clinical and Economic Review issues reports about what medications are and are not worthy of being covered by insurance. Unfortunately, ICER relies on arbitrary and unscientific methodology to make its recommendations.